$SUPN News

MSG Rangers To Replace Arbor Realty Trust In The S&P SmallCap 600 Effective On October 27; Huron Consulting Group To Replace Supernus Pharmaceuticals In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, November 2

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline

Reported Earlier, Supernus Secures Seven Years Of FDA Orphan-Drug Exclusivity For ONAPGO, Seeks Second Supplier Approval By Mid-2027

Supernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl)

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

Supernus Pharmaceuticals: The Merger Is Priced Like A Retreat, But Reads Like A Reverse Takeover

3 Reasons SUPN is Risky and 1 Stock to Buy Instead

Why Did Supernus Pharmaceuticals (SUPN) Move Today?

How Supernus’ Q2 Beat and Raised Guidance Could Reshape Supernus Pharmaceuticals (SUPN) Investors’ Outlook

Branded Pharmaceuticals Stocks Q2 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

Supernus Pharmaceuticals to Participate in September Investor Conferences

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?

Supernus Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

Supernus Pharmaceuticals (SUPN) Stock May Be A Bargain After Merger News

Supernus Pharmaceuticals, Inc. (SUPN) Indivior Pharmaceuticals, Inc., - M&A Call - Slideshow

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

Supernus Pharmaceuticals Inc (SUPN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth ...

Supernus and Indivior merge to create scaled, CNS-focused entity

Supernus Pharmaceuticals Earnings: What To Look For From SUPN